Know Cancer

or
forgot password

Validation of a Screening Tool in Geriatric Oncology


N/A
70 Years
N/A
Not Enrolling
Both
Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Prostate Cancer

Thank you

Trial Information

Validation of a Screening Tool in Geriatric Oncology


OBJECTIVES:

Primary

- Validate a new screening tool (G8).

Secondary

- Validate the French version of the screening tool "Vulnerable Elders Survey (VES-13)".

- Evaluate the merits of the screening tools (G8 and VES-13).

- Assess the screening tool in specific populations.

- Assess the number and type of interventions proposed after thorough geriatric
assessment.

- Compare the two new tools (G8 vs VES-13).

OUTLINE: This is a multicenter study.

During the first consultation, patients have an initial clinical evaluation questionnaire
comprising the G8. They also complete the self-questionnaire VES-13. Within 30 days,
patients have a thorough geriatric assessment, including quality of life and physical
function, by a physician without access to the G8 or VES-13 questionnaires. A blood specimen
is also collected.

Information on health status and quality of life is collected from medical records or from
the doctor after 1 and 5 years.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Histologically confirmed cancer including the following types:

- Colon

- Rectal

- Lung

- Squamous cell carcinoma of the head and neck

- Breast

- Prostate

- Non-Hodgkin lymphoma

- Planning to undergo first-time treatment comprising medicine, surgery, or
radiotherapy

PATIENT CHARACTERISTICS:

- No persons deprived of liberty or under guardianship

- No psychological, familial, social, or geographical reasons that would make
monitoring clinically impossible

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Masking: Open Label, Primary Purpose: Screening

Outcome Measure:

Validation of G8 screening tool

Safety Issue:

No

Principal Investigator

Pierre Soubeyran, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Institut BergoniƩ

Authority:

United States: Federal Government

Study ID:

CDR0000637122

NCT ID:

NCT00963911

Start Date:

June 2008

Completion Date:

Related Keywords:

  • Breast Cancer
  • Colorectal Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Lymphoma
  • Prostate Cancer
  • colon cancer
  • rectal cancer
  • non-small cell lung cancer
  • small cell lung cancer
  • hypopharyngeal squamous cell carcinoma
  • laryngeal squamous cell carcinoma
  • laryngeal verrucous carcinoma
  • lip and oral cavity squamous cell carcinoma
  • oral cavity verrucous carcinoma
  • nasopharyngeal squamous cell carcinoma
  • oropharyngeal squamous cell carcinoma
  • paranasal sinus and nasal cavity squamous cell carcinoma
  • salivary gland squamous cell carcinoma
  • prostate cancer
  • breast cancer
  • adult non-Hodgkin lymphoma
  • Breast Neoplasms
  • Colorectal Neoplasms
  • Head and Neck Neoplasms
  • Lung Neoplasms
  • Lymphoma
  • Prostatic Neoplasms

Name

Location